“Amrubicin Therapy Improves Patients With Refractory Small-Cell Lung Cancer: A Single-Arm Confirmatory Chinese Clinical Study”. Bangladesh Journal of Pharmacology, vol. 11, no. 3, June 2016, pp. 564-9, https://doi.org/10.3329/bjp.v11i3.23953.